Could a simple supplement make rectal cancer treatment more effective?

NCT ID NCT07359989

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether adding leucine, a common amino acid found in food, to standard chemoradiotherapy can help shrink tumors more effectively in people with locally advanced rectal cancer. The researchers believe leucine may interfere with cancer cells' ability to repair DNA damage caused by radiation. The trial will enroll 33 participants and measure how many achieve a complete response (no cancer cells visible after treatment).

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Leucine (a dietary supplement)
What this could lead to
If it works, this could point toward a simple, low-cost way to boost the effectiveness of standard chemoradiotherapy for rectal cancer.
What could go wrong
This is a very early, small (33 people), single-arm trial with no placebo group, so results may not be reliable. Leucine's benefit is unproven, and side effects from the combination are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Second Affiliated Hospital Of Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.